Sep 6, 2025, 12:52
Which Antiarrhythmics Increase Bleeding Risk with Xa Inhibitors?
Thrombosis & Haemostasis Journal (TH Open) shared a post on X:
“What is the risk of Major Bleeding During Concomitant Use of Antiarrhythmics and Oral Factor Xa Inhibitors? Choi et al. found that Amiodarone, Diltiazem and Verapamil were associated with high bleeding risk, while Dronedarone was not.”
Read more here.
Find similar posts on Hemostasis Today.
-
Jul 15, 2026, 13:43Katarina Miljević: New Insights into Recombinant tPA and FXI Inhibition at ISTH 2026
-
Jul 15, 2026, 13:31Sandrine Meunier: ISTH 2026 Highlights Consensus on Pediatric Hemostatic Assessment
-
Jul 15, 2026, 13:20Mauricio Bordonaba: Reflecting on ISTH 2026 and Our Commitment to a Truly Free Hemophilia Life
-
Jul 15, 2026, 07:15Sandrine Horman: Back From an Inspiring Week at ISTH 2026
-
Jul 15, 2026, 06:55Christopher Devany: Great to Be Here in Paris for the ISTH 2026
-
Jul 15, 2026, 06:45Viviana Di Fabio: The Synergy Between Hematology and Hemostasis Starts with Platelets
-
Jul 15, 2026, 06:35Wolfgang Miesbach: Paediatric Phase 3 BASIS KIDS Data for Marstacimab at ISTH 2026
-
Jul 15, 2026, 06:06Marija Tashkovska: Advancing Knowledge and Clinical Practice Through ISTH 2026
-
Jul 15, 2026, 05:55Hong Chow: Where Science Meets Art at ISTH 2026